(Q36272592)

13 August 2017

1 reference

title

Significance of Epstein-Barr virus (EBV) load and interleukin-10 in post-transplant lymphoproliferative disorders (English)

1 reference

13 August 2017

0 references

0 references

Muti G

1

1 reference

13 August 2017

Mancini V

series ordinal

2

1 reference

13 August 2017

Ravelli E

series ordinal

3

1 reference

13 August 2017

Morra E

series ordinal

4

1 reference

13 August 2017

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

46

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

1397-1407

1 reference

Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus and oncogenesis: from latent genes to tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

A semiquantitative PCR method (SQ-PCR) to measure Epstein–Barr virus (EBV) load: its application in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Quantitation of Epstein-Barr virus DNA in the blood of adult liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative dis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Usefulness of quantitative real-time polymerase chain reaction in following up patients with Epstein-Barr virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Lymphoproliferative disease after allogeneic stem cell transplantation--pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus and post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The real-time polymerase chain reaction-guided modulation of immunosuppression enables the pre-emptive management of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Post-transplant lymphoproliferative disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Predictive value of Epstein-Barr virus genome copy number and BZLF1 expression in blood lymphocytes of transplant recipients at risk for lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Immunological aspects of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

B-cell-derived IL-10: production and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Distinct profiles of human B cell effector cytokines: a role in immune regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The interleukin-10 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

In situ detection of lytic Epstein-Barr virus infection: expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Interleukin-10 in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter −592 C/C genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Viral interleukin-10 in chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

The role of cytokines in the pathogenesis and management of AIDS-related lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500160272

10.1080/10428190500160272

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference